艾迪配合化疗治疗非小细胞肺癌临床疗效观察

目的 :观察艾迪注射液加化疗治疗非小细胞肺癌 (NSCLC)的疗效。方法 :1998年 10月 - 2 0 0 0年 12月进行了艾迪注射液加化疗治疗NSCLC的研究。 6 3例随机分为两组 ,治疗组为化疗加艾迪注射液治疗 ,对照组为单纯化疗。结果 :治疗组 (33例 )与对照组 (30例 )的近期客观疗效分别为 6 3 6 %和5 6 7%、临床症状改善率分别为 6 9 7%和 4 0 0 %、生存质量改善率分别为 5 4 5 %和 30 0 %。经统计学处理 ,两组在临床症状及生存质量改善方面差异有显著意义 ,P <0 0 5。结论 :艾迪注射液对接受化疗的NSCLC患者 ,有助于临床症状的进一步改善和生存质量的提高

Clinical Study of Aidi Injection Combined with Chemotherapy in the Treatment of Non-small Cell Lung Cancer

Objective To investigate the efficacy of AiDi injection combined with chemotherapy in the treatment of non small cell lung cancer (NSCLC).Methods From Oct.1998 to Dec.2000,63 patients with NSCLC were enrolled in this study and divided randomly into two groups.Thirty three patients received Aidi injection in combination with chemotherapy (the study group),and 30 patients received chemotherapy alone (the control group).Results The response rates in the study group and control group were 63 6% and 56 7%, respectively.The clinical symptoms and the quality of life were significantly different between the two groups, P <0 05.Conclusions Aidi injection was helpful to improving the clinical symptoms and the quality of life for patients with NSCLC who received chemotherapy. China J Cancer Prev Treat,2003,10(5):510-511